| Literature DB >> 33030622 |
Andrea Zini1, Michele Romoli2,3, Mauro Gentile1, Ludovica Migliaccio1, Cosimo Picoco4, Oscar Dell'Arciprete4, Luigi Simonetti5, Federica Naldi1, Laura Piccolo1, Giovanni Gordini4, Francesco Tagliatela5, Vincenzo Bua4, Luigi Cirillo6,7, Ciro Princiotta6, Carlo Coniglio4, Carlo Descovich8, Pietro Cortelli9,10.
Abstract
INTRODUCTION: A reduction of the hospitalization and reperfusion treatments was reported during COVID-19 pandemic. However, high variability in results emerged, potentially due to logistic paradigms adopted. Here, we analyze stroke code admissions, hospitalizations, and stroke belt performance for ischemic stroke patients in the metropolitan Bologna region, comparing temporal trends between 2019 and 2020 to define the impact of COVID-19 on the stroke network.Entities:
Keywords: COVID-19; Epidemiology; Ischemic stroke; Transient ischemic-attack
Mesh:
Year: 2020 PMID: 33030622 PMCID: PMC7541754 DOI: 10.1007/s10072-020-04754-2
Source DB: PubMed Journal: Neurol Sci ISSN: 1590-1874 Impact factor: 3.307
Characteristics of included cohorts (whole population)
| Cohort-2019 ( | Cohort-2020 ( | |
|---|---|---|
| Female, | 68 (49.3%) | 67 (46.2%) |
| Age, mean ± SD | 75.2 ± 13.8 | 71.7 ± 18 |
| Cerebrovascular disease | ||
| Intracerebral hemorrhage, | 21 (15.2%) | 17 (11.7%) |
| Transient ischemic attack, | 20 (14.5%) | 10 (6.9%)* |
| Ischemic stroke, | 97 (70.3%) | 118 (81.4%)* |
| NIHSS, mean ± SD | 7.6 ± 7.1 | 9.2 ± 7.6 |
| Month | ||
| March, | 62 (44.9%) | 72 (49.7%) |
| April, | 76 (55.1%) | 73 (50.3%) |
*p < 0.05
NIHSS National Institute of Health Stroke Scale
Demographic and clinical details, treatment and timings and timings for patients admitted with acute ischemic stroke
| Cohort-2019 ( | Cohort-2020 ( | |
|---|---|---|
| Female, | 54 (55.1%) | 56 (47.5%) |
| Age, mean ± SD | 76.6 ± 13.7 | 72.9 ± 16.6 |
| NIHSS, mean ± SD | 8.9 ± 7.2 | 9.5 ± 7.4 |
| Stroke severity, | ||
| Minor stroke | 2 (2.1%) | 0 (0%) |
| Moderate stroke | 78 (80.4%) | 88 (74.6%) |
| Moderate to severe | 6 (6.2%) | 21 (17.8%)* |
| Severe | 11 (11.3%) | 9 (7.6%) |
| Reperfusion, | 44 (45.4%) | 63 (53.4%) |
| IVT only | 23 (23.7%) | 21 (17.8%) |
| EVT only | 7 (7.2%) | 12 (10.2%) |
| IVT + EVT | 14 (14.4%) | 30 (25.4%)* |
| All IVT | 37 (38.1%) | 51 (43.2%) |
| All EVT | 21 (21.6%) | 42 (35.6%)* |
| Reperfusion timing, mean ± SD# | ||
| Stroke to call | 33.7 ± 40.2 | 65.5 ± 104.3 |
| Call to rescue | 15.4 ± 7.9 | 12.9 ± 5.8 |
| Rescue to door | 53.2 ± 38 | 44 ± 26.6 |
| Door to scan | 28 ± 12.6 | 36.7 ± 14.6* |
| Door to needle | 67.8 ± 20.8 | 72.6 ± 34.3 |
| Stroke to needle | 164.5 ± 51.8 | 173.9 ± 71.2 |
| Door to groin | 116.9 ± 39 | 118.8 ± 55.7 |
| Groin to recanalization | 53.1 ± 35.6 | 66.8 ± 43.9 |
| Door to recanalization | 170 ± 53.4 | 186 ± 82.8 |
| Stroke to recanalization | 337.7 ± 310.2 | 361 ± 270 |
*p value < 0.05
#Complete timing data available for 33/44 patients in cohort-2019 and 49/63 patients in cohort-2020
Fig. 1Temporal trends of reperfusion treatments across weeks in 2019 and 2020 cohorts, starting from 1/3 (week 9) to 30/4 (week 18). EVT endovascular thrombectomy, IVT intravenous thrombolysis